Cargando…
Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
Ovarian cancer has a poor outcome because it is usually detected at advanced tumor stages, and the majority of the patients develop disease relapse as a result of chemotherapy resistance. This most lethal gynecological malignancy metastasizes within the peritoneal fluid or ascites to pelvic and dist...
Autores principales: | Schwarzenbach, Heidi, Gahan, Peter B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992516/ https://www.ncbi.nlm.nih.gov/pubmed/35582568 http://dx.doi.org/10.20517/cdr.2019.51 |
Ejemplares similares
-
Interplay between LncRNAs and microRNAs in Breast Cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2023) -
Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients
por: Schwarzenbach, Heidi, et al.
Publicado: (2019) -
MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019) -
Predictive value of exosomes and their cargo in drug response/resistance of breast cancer patients
por: Schwarzenbach, Heidi, et al.
Publicado: (2020) -
Exosomes in Immune Regulation
por: Schwarzenbach, Heidi, et al.
Publicado: (2021)